OpenAI is intensifying its focus on healthcare with strategic appointments, including Nate Gross from Doximity and Ashley Alexander from Instagram. Gross will spearhead OpenAI’s healthcare go-to-market strategy, collaborating with clinicians and researchers to develop new technologies. Alexander, as Vice President of Product, will focus on consumer-facing solutions. This shift marks a significant transition, with OpenAI moving beyond merely powering other companies’ products to developing its own healthcare technologies. CEO Sam Altman highlighted the capabilities of ChatGPT in healthcare during the GPT-5 launch, emphasizing its expertise in assisting users with health-related decisions. OpenAI released HealthBench in May, a tool for evaluating health AI safety and accuracy. With competition from firms like Microsoft and Palantir, OpenAI aims to accelerate its healthcare ambitions while maintaining existing partnerships, such as with Penda Health and Summer Health. The company continues expanding its team, seeking talent for additional roles in healthcare AI.
Source link
